Cinzia Costa

Mansfield University — United States

Neuroscience · Life Sciences

47h-index6.9kcitations169works3.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuroscience and Neuropharmacology Research(73), Epilepsy research and treatment(67), Pharmacological Effects and Toxicity Studies(41), Neurological disorders and treatments(16), Alzheimer's disease research and treatments(14)

Publications169 total

Neuronal hyperexcitability: A key to unraveling hippocampal synaptic dysfunction in Lafora disease
Epilepsia·2025Open Access
Advances in gene therapy for Lafora disease: Intravenous recombinant adeno‐associated virus‐mediated delivery of <i>EPM2A</i> and <i>EPM2B</i> genes
Clinical and Translational Medicine·2025· 1 citedOpen Access
Etiological diagnosis of late‐onset epilepsy: A key priority for Italian epileptologists – Insights from a LICE survey
Epilepsia Open·2025Open Access
Clinical course and management challenges in Lafora disease: a narrative analysis in an Apulian cohort
Orphanet Journal of Rare Diseases·2025Open Access
Oligomeric alpha-synuclein causes early synaptic dysfunction of the corticostriatal pathway associated with non-motor symptoms
npj Parkinson s Disease·2025· 5 citedOpen Access
Systematic review and meta-analysis of microbiota-gut-astrocyte axis perturbation in neurodegeneration, brain injury, and mood disorders
Brain Behavior & Immunity - Health·2025· 2 citedOpen Access
Neuronal Hyperexcitability: A Key to Unravelling Hippocampal Synaptic Dysfunctions in Lafora Disease
2025Open Access
<i>MBOAT7</i> encephalopathy: Characterizing the neurology and epileptology
Epilepsia·2025Open Access
Adjunctive Brivaracetam in People with Epilepsy and Intellectual Disability: Evidence from the BRIVAracetam Add-On First Italian netwoRk Study
Neurology and Therapy·2025· 2 citedOpen Access
Safety and efficacy of concomitant treatment with non‐vitamin K antagonist oral anticoagulants and antiseizure medications: A propensity score matching cohort study
Epilepsia·2024· 6 cited
Evaluating bexicaserin for the treatment of developmental epileptic encephalopathies
Expert Opinion on Pharmacotherapy·2024· 16 cited
Gene therapy for Lafora disease in the Epm2a mouse model
Molecular Therapy·2024· 12 citedOpen Access
Clarifying the role of D1 receptor signalling in Alzheimer's‐related epilepsy commentary on Szabo et al. (2024)
European Journal of Neuroscience·2024Open Access
Incidence and Risk Factors Epilepsy in Patients with Dementia: A Population-Based Study Using Regional Healthcare Databases in Umbria
Journal of Alzheimer s Disease·2024· 2 cited
Author response for "Clarifying the role of D1 receptor signalling in Alzheimer's‐related epilepsy commentary on Szabo et al. (2024)"
2024
Author response for "Clarifying the role of D1 receptor signalling in Alzheimer's‐related epilepsy commentary on Szabo et al. (2024)"
2024
Cannabidiol: metabolism and clinical efficacy in epileptic patients
Expert Opinion on Drug Metabolism & Toxicology·2024· 5 cited
Locally Synthetized 17-β-Estradiol Reverses Amyloid-β-42-Induced Hippocampal Long-Term Potentiation Deficits
International Journal of Molecular Sciences·2024· 4 citedOpen Access
Thalamocortical dysrhythmia in patients with delirium: an EEG possible marker of prodromal dementia with Lewy bodies
Alzheimer s & Dementia·2023Open Access
The broad-spectrum activity of perampanel: state of the art and future perspective of AMPA antagonism beyond epilepsy
Frontiers in Neurology·2023· 28 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

Paolo Calabresi(41), Alessandro Tozzi(17), Massimiliano Di Filippo(14), Michela Tantucci(13), Barbara Picconi(12), Giorgio Bernardi(9), Sabrina Siliquini(9), Paola Sarchielli(9), Antonio de Iure(8), Veronica Ghiglieri(8), Vincenzo Belcastro(8), Lucilla Parnetti(7), Francesco Pisani(6), Paolo Eusebi(6), Antonio Pisani(5), Michele Romoli(5), Fabrizio Gardoni(5), Carmela Giampà(5), Letizia Maria Cupini(5), Diego Centonze(5)